EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants

Kai Liu, Yuan Shi

JAMA · 2024

DOI: 10.1001/jama.2023.24527 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JAMA, 2024. Verfasst von Kai Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Kunming Children's Hospital, Kunming, China. Hauptthemen laut MEDLINE: Infant, Premature, Pulmonary Surfactants, Surface-Active Agents. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To the Editor A recent 2-year follow-up study1 compared the effect of minimally invasive surfactant therapy (MIST) vs control (placebo) on neurodevelopment disability and death at 2 years’ corrected age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant, PrematurePulmonary SurfactantsSurface-Active AgentsHumansInfantInfant, NewbornLipoproteinsTreatment Outcome

Substanzen

LipoproteinsPulmonary SurfactantsSurface-Active Agents

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Kunming Children's Hospital, Kunming, China.
  • National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.

Zitieren

APA

Liu, K., & Shi, Y. (2024). Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants. JAMA. https://doi.org/10.1001/jama.2023.24527

Vancouver

Liu K, Shi Y. Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants. JAMA. 2024. doi:10.1001/jama.2023.24527

BibTeX
@article{Liu2024,
  author = {Liu, Kai and Shi, Yuan},
  title = {Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2023.24527}
}
Kostenlos starten →